Microbio Co., Ltd. was established in 1989, went public in 1990 and went listed in OTC market in 1995. In July 1995, it set up its own direct sales business Daigo clear, entering the direct market. In January 1996 its new plant drug MS-20 was approved by the FDA for Phase II human clinical trials. Microbio Co., Ltd. has got its main annual revenue relying on health food; its strategy is to maintain the development of new drugs with the income from health food sales.
Headquarters
18F-1,No.3,Yuan Qu St,Taipei 115,Taiwan,R.O.C
Taipei City; Taipei City;
Contact Details: Purchase the Microbio Co., Ltd. (中天生物科技股份有限公司) report to view the information.
Website: http://twmicrobio.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service